• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Prior SARS-CoV-2 infection is associated with protection against reinfection

byCyrus AyubchaandTeddy Guo
April 28, 2021
in Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Previous infection from SARS-CoV-2 was linked to an 84% lower incidence of reinfection.

2. Median interval between primary infection and reinfection of COVID-19 was greater than 200 days.

Evidence Rating Level: 2 (Good)

Study Rundown: While it has been suggested that a history of SARS-CoV-2 infection confers protection against subsequent infection, little is known about the degree and length of protection acquired from natural infection. This multicenter prospective cohort study enrolled healthcare workers, support staff, and administrative staff working at hospitals who could remain enrolled for at least 12 months of follow-up. Participants were required to complete questionnaires on symptoms and exposures every two weeks as well as undergo SARS-CoV-2 PCR and antibody testing every two to four weeks. This study found that there was a nearly 84% reduced risk of infection in individuals with prior infection or who were antibody-positive at enrollment as opposed to those who had not been infected previously. Study results further suggested at least a seven-month window of protection against infection. This study was strengthened by its large number of subjects and the length of follow-up. Nevertheless, this study is observational and as such, does not control the probability or degree of exposure to SARS-CoV-2 each individual experienced. With vaccine availability increasing steadily, future studies may look to compare the protective effects of antibodies from a natural infection and those derived from vaccinations.

Click to read the study in the Lancet

Relevant Reading: What we know about covid-19 reinfection so far

In-Depth [prospective cohort]: This observational study utilized a longitudinal prospective cohort to assess the risk of SARS-CoV-2 reinfection. This study enrolled hospital staff from NHS hospitals across the UK from June 18, 2020, to Dec 31, 2020; 25,661 participants were utilized in the subsequent analysis. Data was collected up to and including Jan 11, 2021. Subjects were divided into the two cohorts that had either tested positive or not previously tested positive for SARS-CoV-2. Specifically, the positive cohort included those who were antibody positive on or before enrollment or had a positive PCR result before enrollment. The negative cohort included those with prior negative antibody tests and no prior positive PCR or antibody test. Reinfections were clinically determined given the certainty of diagnosis and symptom status, according to testing and medical records. Of those in the previously positive and negative cohorts, the infection rates were 1.87% (155/8,278) and 9.80% (1,704/17,383), respectively. An adjusted incidence rate ratio (aIRR) was calculated for each cohort concerning period and site to conclude that reinfection risk was reduced by at least 84% (aIRR 0.159, 95%CI [0.13–0.19]). For those with a PCR-confirmed reinfection, the median time between the primary infection and reinfection positive tests was 201 days (range, 95-297).

RELATED REPORTS

Unvaccinated status increases risk of long COVID symptoms

The 2 Minute Medicine Podcast Episode 6

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CoronaviruscovidCOVID-19 antibodiescovid-19 diagnosiscovid-19 infectionCOVID-19 reinfectionSARS-CoV-2sars-cov-2 variants
Previous Post

Dexmedetomidine and propofol had similar outcomes in septic, mechanically ventilated adults

Next Post

#VisualAbstract: Psilocybin does not significantly improve depressive scores compared to escitalopram

RelatedReports

Medical vaccine exemptions increase after elimination of nonmedical exemptions
Infectious Disease

Unvaccinated status increases risk of long COVID symptoms

January 25, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media

December 27, 2022
Palliative chemotherapy associated with more ICU treatment at end-of-life
Infectious Disease

Evolving standard of care guidelines have improved outcomes in hospitalized COVID-19 patients

December 23, 2022
Next Post
#VisualAbstract: Use of bamlanivimab may benefit patients with mild to moderate COVID-19 infection

#VisualAbstract: Psilocybin does not significantly improve depressive scores compared to escitalopram

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Sex-related disparities in cardiovascular health care among patients with premature atherosclerotic cardiovascular disease

Novel coronavirus identified from patients with pneumonia in Wuhan, China

ChAdOx1 nCov-19 AstraZeneca COVID-19 vaccine not effective against B.1.351 variant

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options